What Happened
A contract registered nurse working at a Kentucky health care facility for elderly and infirm patients stole morphine from three of her patients and replaced it with water and blue food coloring, then administered the tampered substance to at least one of them.
Between January and August 2023, the nurse worked as a contract registered nurse at several facilities in Kentucky, including a health care facility in Lawrenceburg that focused on care for the elderly and infirm. On August 27, 2023, she took morphine that had been prescribed for three patients she was treating, all of whom had significant disease and pain concerns. She replaced the stolen morphine with water and blue food coloring to resemble the real medication. In total, she took at least seven syringes of stolen morphine, and administered the tampered morphine to at least one of the patients in her care.
She pleaded guilty to tampering with a consumer product. On March 25, 2025, she was sentenced to 60 months in federal prison — she must serve 85 percent of the sentence under federal law — followed by three years of supervised release.
What Went Wrong
A contract nurse was able to steal morphine from multiple vulnerable patients simultaneously and substitute a visibly similar but inert liquid. Key failure points:
- A crude substitute went undetected before administration. Water dyed with food coloring is not a sophisticated tampering method, yet it passed unnoticed at the bedside for at least one patient, indicating no visual or chemical verification occurred before administration.
- Elderly, high-pain patients could not reliably self-report ineffective medication. Patients with significant disease and pain concerns may not have been able to clearly communicate that their pain medication was not working, delaying detection.
- Contract staff access was not independently verified. As with other contract and travel nurse cases, there was no described mechanism for cross-checking a contract nurse's controlled-substance handling against a second clinician.
- Multiple patients affected before detection. Diversion from three separate patients' medication occurred in a single episode without triggering an immediate discrepancy alert.
How It Could Have Been Prevented
- Require two-person verification for controlled substance withdrawal and administration in facilities serving high-pain, vulnerable populations.
- Train staff and caregivers to regularly assess and document whether pain medication is achieving its intended clinical effect, and escalate when it is not.
- Perform routine visual and chemical spot-checks of liquid controlled substances, especially syringes prepared in advance of administration.
- Apply the same access logging and reconciliation standards to contract and agency nurses as to permanent staff.
- Investigate immediately when multiple patients under one nurse's care report or show signs of inadequate pain relief around the same time.
Related Guidance
- Diversion prevention checklist — Self-assessment for facilities serving elderly and infirm patients.
- Employee Screening & Fitness for Duty — Vetting standards for contract and agency staff with controlled-substance access.
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion by clinical staff.
- Patient Notification After Drug Diversion — When and how to notify potentially exposed patients.
- Investigation Playbook — How to run an internal diversion investigation when staff or product integrity is questioned.